Malaria Prevention for European Travelers to the Indian Subcontinent
Author Information
Author(s): Behrens RH, Bisoffi Z, Björkman A, Gascon J, Hatz C, Jelinek T, Legros F, Mühlberger N, Voltersvik P
Primary Institution: Hospital for Tropical Diseases & London School of Hygiene & Tropical Medicine, London, UK
Hypothesis
Is the use of chemoprophylaxis necessary for travelers from Europe to the Indian Subcontinent?
Conclusion
The study suggests that the recommendation for non-selective prescribing of malaria chemoprophylaxis for travelers to India, Pakistan, Bangladesh, and Sri Lanka should be dropped.
Supporting Evidence
- The proportion of malaria cases from the Indian Subcontinent in 2004 was between 1.4% and 4.6% of total imported cases.
- Imported malaria cases reported from the ISC have been declining.
- Most travelers to the ISC are not using chemoprophylaxis despite the risk of malaria.
Takeaway
The study found that many travelers to India and nearby countries don't need malaria pills because the risk of getting malaria is very low.
Methodology
Analysis of malaria cases reported from the Indian Subcontinent to eight European countries between 1999 and 2004.
Potential Biases
Potential bias in reporting and data collection methods across different countries.
Limitations
The study relies on reported cases, which may not capture all instances of malaria.
Participant Demographics
UK residents traveling to the Indian Subcontinent.
Statistical Information
Confidence Interval
95% CI 27–46
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website